查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1872340

灌注式生物反应器：全球市场份额和排名、总收入和需求预测（2025-2031年）

Perfusion Bioreactors - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球灌註生物反应器市场规模估计为 7.03 亿美元，预计到 2031 年将达到 11.53 亿美元，在预测期（2025-2031 年）内复合年增长率为 7.2%。

本报告对近期与灌註生物反应器相关的关税调整和国际战略反制措施进行了全面评估，包括其对跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响。

灌流是一种维持细胞培养生物反应器的方法，在这种方法中，等体积的培养基被添加到反应器中，并从反应器中移除，同时将细胞保持在反应器内。与传统的补料批次生物反应器相比，灌流生物反应器在可扩展性和满足日益增长的需求方面具有许多优势。灌流生物反应器透过持续供应新鲜培养基和移除废培养基，可实现长达数月的长期培养，同时保持细胞在培养中存活。在灌流过程中，有多种方法可以实现维持细胞培养和移除废培养基。

全球主要的灌註生物反应器生产商包括赛多利斯（Sartorius AG）、赛特瓦（Cytiva）、赛默飞世尔（Thermo Fisher）、爱本多（Eppendorf AG）和ZETA）。排名前五的全球生产商占据了超过79%的市场。目前，北美是全球最大的灌註生物反应器市场，占超过40%的市场份额，其次是亚太地区和欧洲市场，这两个地区合计占超过40%的市场份额。

灌注式生物反应器市场的主要驱动因素包括：

生物製药产业的快速发展

随着人们健康意识的增强，对生物製药产品的需求持续成长。生物製药产业的快速发展是灌注式生物反应器的主要应用领域之一，直接推动了市场对灌注式生物反应器的需求。在研发和生产过程中，生物製药企业需要高效稳定的生物反应器来支持细胞培养、病毒扩增等关键工艺，而灌注式生物反应器正是满足这些需求的重要工具。

生物技术的持续进步

生物技术的快速发展为灌注式生物反应器带来了更多应用和可能性。随着新型细胞培养、生物合成和基因编辑技术的出现，灌注式生物反应器的功能日益多样化，使其能够满足更多种类生物製药和生物技术产品的生产需求。此外，生物技术的进步也推动着灌注式生物反应器技术的持续创新和完善，从而不断提高其生产效率和性能。

政府政策支持

世界各国政府纷纷推出政策，促进生物製药和生技产业的发展。这些政策不仅为生物製药企业提供财政支持和税收优惠等扶持措施，也促进相关产业链的建设和改善。在这些政策的推动下，生物製药和生技产业迅速发展，进而带动了灌注式生物反应器市场的成长。

市场竞争与技术创新

全球灌流式生物反应器市场竞争激烈，主要企业积极研发新产品、开拓新市场。这种市场竞争促进了灌注式生物反应器技术的持续创新和进步，从而提升了产品的性能和品质。同时，公司间的合作与併购也加速了该技术的推广与应用，进一步推动了市场成长。

新兴市场机会

随着生物相似药和基因编辑等新兴领域的快速发展，灌注式生物反应器有望在这些领域中广泛应用。这些新兴市场为灌注式生物反应器提供了新的发展机会和成长空间。例如，在生物相似药领域，灌注式生物反应器可用于生产高品质的生物相似药；在基因编辑领域，灌注式生物反应器可用于支持基因编辑细胞的增殖和分化等过程。

摘要，灌注式生物反应器市场的主要驱动因素包括生物製药产业的快速发展、生物技术的不断进步、政府政策支援、市场竞争和技术创新以及新兴市场机会。这些因素共同推动了灌注式生物反应器市场的快速成长和发展。

本报告旨在按地区/国家、类型和应用对全球灌註生物反应器市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

灌注式生物反应器市场规模、估算和预测以销售量（千台）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定灌注式生物反应器业务/成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Sartorius AG
  • Cytiva
  • Thermo Fisher
  • Eppendorf AG
  • ZETA
  • Infors HT
  • Applikon Biotechnology（Getinge）
  • Bioengineering AG
  • 3D Biotek
  • PBS Biotech, Inc.
  • Cell Culture Company
  • Zellwerk GmbH

按类型分類的细分市场

  • 小规模（小于100公升）
  • 中型（100-1000公升）
  • 大型（超过1000公升）

应用领域

  • 生物製药
  • 生物技术
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Perfusion Bioreactors was estimated to be worth US$ 703 million in 2024 and is forecast to a readjusted size of US$ 1153 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Perfusion Bioreactors cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor. Perfusion bioreactors offer several advantages over traditional fed-batch bioreactors when addressing problems of scalability and increasing demand. Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.

The main global perfusion bioreactor manufacturers include Sartorius AG,Cytiva,Thermo Fisher,Eppendorf AG and ZETA, etc. The top five global manufacturers account for more than 79% of the market share. Currently, North America is the world's largest perfusion bioreactor market, accounting for more than 40% of the market share, followed by the Asia-Pacific and European markets, which together account for more than 40% of the market share.

The driving factors of the perfusion bioreactor market mainly include the following:

The rapid development of the biopharmaceutical industry

As people pay more attention to health, the demand for biopharmaceutical products continues to grow. As one of the main application areas of perfusion bioreactors, the rapid development of the biopharmaceutical industry has directly promoted the market demand for perfusion bioreactors. In the process of research and development and production, biopharmaceutical companies need efficient and stable bioreactors to support key steps such as cell culture and virus amplification, and perfusion bioreactors are important tools to meet these needs.

Continuous progress in biotechnology

The rapid development of biotechnology has provided more application areas and possibilities for perfusion bioreactors. New cell culture technology, biosynthesis technology, and gene editing technology continue to emerge, making the functions of perfusion bioreactors more diversified and able to meet the production needs of more types of biopharmaceuticals and biotechnology products. In addition, the advancement of biotechnology has also promoted the continuous innovation and upgrading of perfusion bioreactor technology, improving its production efficiency and performance.

Support from government policies

Governments of various countries have introduced policies to encourage the development of biopharmaceutical and biotechnology industries. These policies not only provide biopharmaceutical companies with preferential measures such as financial support and tax incentives, but also promote the construction and improvement of related industrial chains. Driven by these policies, the biopharmaceutical and biotechnology industries have developed rapidly, which in turn has driven the growth of the perfusion bioreactor market.

Market competition and technological innovation

The global perfusion bioreactor market is highly competitive, and major companies are actively developing new products and expanding new markets. This market competition has promoted the continuous innovation and upgrading of perfusion bioreactor technology, improving the performance and quality of products. At the same time, cooperation and mergers and acquisitions between companies have also accelerated the dissemination and application of technology, further promoting market growth.

Emerging market opportunities

With the rapid development of emerging fields such as biosimilars and gene editing, perfusion bioreactors have broad application prospects in these fields. These emerging markets provide new development opportunities and growth space for perfusion bioreactors. For example, in the field of biosimilars, perfusion bioreactors can be used to produce high-quality biosimilars; in the field of gene editing, perfusion bioreactors can be used to support processes such as the expansion and differentiation of gene-edited cells.

In summary, the driving factors of the perfusion bioreactor market mainly include the rapid development of the biopharmaceutical industry, the continuous advancement of biotechnology, the support of government policies, market competition and technological innovation, and emerging market opportunities. These factors have jointly promoted the rapid growth and development of the perfusion bioreactor market.

This report aims to provide a comprehensive presentation of the global market for Perfusion Bioreactors, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Perfusion Bioreactors by region & country, by Type, and by Application.

The Perfusion Bioreactors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Perfusion Bioreactors.

Market Segmentation

By Company

  • Sartorius AG
  • Cytiva
  • Thermo Fisher
  • Eppendorf AG
  • ZETA
  • Infors HT
  • Applikon Biotechnology (Getinge)
  • Bioengineering AG
  • 3D Biotek
  • PBS Biotech, Inc.
  • Cell Culture Company
  • Zellwerk GmbH

Segment by Type

  • Small Scale (≤100 Liters)
  • Mid-Scale (100 to 1,000 Liters)
  • Large Scale (>1,000 Liters)

Segment by Application

  • Biopharmaceutical
  • Biotechnology
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Perfusion Bioreactors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Perfusion Bioreactors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Perfusion Bioreactors in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Perfusion Bioreactors Product Introduction
  • 1.2 Global Perfusion Bioreactors Market Size Forecast
    • 1.2.1 Global Perfusion Bioreactors Sales Value (2020-2031)
    • 1.2.2 Global Perfusion Bioreactors Sales Volume (2020-2031)
    • 1.2.3 Global Perfusion Bioreactors Sales Price (2020-2031)
  • 1.3 Perfusion Bioreactors Market Trends & Drivers
    • 1.3.1 Perfusion Bioreactors Industry Trends
    • 1.3.2 Perfusion Bioreactors Market Drivers & Opportunity
    • 1.3.3 Perfusion Bioreactors Market Challenges
    • 1.3.4 Perfusion Bioreactors Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Perfusion Bioreactors Players Revenue Ranking (2024)
  • 2.2 Global Perfusion Bioreactors Revenue by Company (2020-2025)
  • 2.3 Global Perfusion Bioreactors Players Sales Volume Ranking (2024)
  • 2.4 Global Perfusion Bioreactors Sales Volume by Company Players (2020-2025)
  • 2.5 Global Perfusion Bioreactors Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Perfusion Bioreactors Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Perfusion Bioreactors Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Perfusion Bioreactors
  • 2.9 Perfusion Bioreactors Market Competitive Analysis
    • 2.9.1 Perfusion Bioreactors Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Perfusion Bioreactors Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfusion Bioreactors as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Small Scale (<=100 Liters)
    • 3.1.2 Mid-Scale (100 to 1,000 Liters)
    • 3.1.3 Large Scale (>1,000 Liters)
  • 3.2 Global Perfusion Bioreactors Sales Value by Type
    • 3.2.1 Global Perfusion Bioreactors Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Perfusion Bioreactors Sales Value, by Type (2020-2031)
    • 3.2.3 Global Perfusion Bioreactors Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Perfusion Bioreactors Sales Volume by Type
    • 3.3.1 Global Perfusion Bioreactors Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Perfusion Bioreactors Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Perfusion Bioreactors Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Perfusion Bioreactors Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biopharmaceutical
    • 4.1.2 Biotechnology
    • 4.1.3 Others
  • 4.2 Global Perfusion Bioreactors Sales Value by Application
    • 4.2.1 Global Perfusion Bioreactors Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Perfusion Bioreactors Sales Value, by Application (2020-2031)
    • 4.2.3 Global Perfusion Bioreactors Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Perfusion Bioreactors Sales Volume by Application
    • 4.3.1 Global Perfusion Bioreactors Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Perfusion Bioreactors Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Perfusion Bioreactors Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Perfusion Bioreactors Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Perfusion Bioreactors Sales Value by Region
    • 5.1.1 Global Perfusion Bioreactors Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Perfusion Bioreactors Sales Value by Region (2020-2025)
    • 5.1.3 Global Perfusion Bioreactors Sales Value by Region (2026-2031)
    • 5.1.4 Global Perfusion Bioreactors Sales Value by Region (%), (2020-2031)
  • 5.2 Global Perfusion Bioreactors Sales Volume by Region
    • 5.2.1 Global Perfusion Bioreactors Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Perfusion Bioreactors Sales Volume by Region (2020-2025)
    • 5.2.3 Global Perfusion Bioreactors Sales Volume by Region (2026-2031)
    • 5.2.4 Global Perfusion Bioreactors Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Perfusion Bioreactors Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Perfusion Bioreactors Sales Value, 2020-2031
    • 5.4.2 North America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Perfusion Bioreactors Sales Value, 2020-2031
    • 5.5.2 Europe Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Perfusion Bioreactors Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Perfusion Bioreactors Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Perfusion Bioreactors Sales Value, 2020-2031
    • 5.7.2 South America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Perfusion Bioreactors Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Perfusion Bioreactors Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Perfusion Bioreactors Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Perfusion Bioreactors Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Perfusion Bioreactors Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Perfusion Bioreactors Sales Value, 2020-2031
    • 6.3.2 United States Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Perfusion Bioreactors Sales Value, 2020-2031
    • 6.4.2 Europe Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Perfusion Bioreactors Sales Value, 2020-2031
    • 6.5.2 China Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Perfusion Bioreactors Sales Value, 2020-2031
    • 6.6.2 Japan Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Perfusion Bioreactors Sales Value, 2020-2031
    • 6.7.2 South Korea Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Perfusion Bioreactors Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Perfusion Bioreactors Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Perfusion Bioreactors Sales Value, 2020-2031
    • 6.9.2 India Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Perfusion Bioreactors Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Sartorius AG
    • 7.1.1 Sartorius AG Company Information
    • 7.1.2 Sartorius AG Introduction and Business Overview
    • 7.1.3 Sartorius AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Sartorius AG Perfusion Bioreactors Product Offerings
    • 7.1.5 Sartorius AG Recent Development
  • 7.2 Cytiva
    • 7.2.1 Cytiva Company Information
    • 7.2.2 Cytiva Introduction and Business Overview
    • 7.2.3 Cytiva Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Cytiva Perfusion Bioreactors Product Offerings
    • 7.2.5 Cytiva Recent Development
  • 7.3 Thermo Fisher
    • 7.3.1 Thermo Fisher Company Information
    • 7.3.2 Thermo Fisher Introduction and Business Overview
    • 7.3.3 Thermo Fisher Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Thermo Fisher Perfusion Bioreactors Product Offerings
    • 7.3.5 Thermo Fisher Recent Development
  • 7.4 Eppendorf AG
    • 7.4.1 Eppendorf AG Company Information
    • 7.4.2 Eppendorf AG Introduction and Business Overview
    • 7.4.3 Eppendorf AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Eppendorf AG Perfusion Bioreactors Product Offerings
    • 7.4.5 Eppendorf AG Recent Development
  • 7.5 ZETA
    • 7.5.1 ZETA Company Information
    • 7.5.2 ZETA Introduction and Business Overview
    • 7.5.3 ZETA Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 ZETA Perfusion Bioreactors Product Offerings
    • 7.5.5 ZETA Recent Development
  • 7.6 Infors HT
    • 7.6.1 Infors HT Company Information
    • 7.6.2 Infors HT Introduction and Business Overview
    • 7.6.3 Infors HT Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Infors HT Perfusion Bioreactors Product Offerings
    • 7.6.5 Infors HT Recent Development
  • 7.7 Applikon Biotechnology (Getinge)
    • 7.7.1 Applikon Biotechnology (Getinge) Company Information
    • 7.7.2 Applikon Biotechnology (Getinge) Introduction and Business Overview
    • 7.7.3 Applikon Biotechnology (Getinge) Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Applikon Biotechnology (Getinge) Perfusion Bioreactors Product Offerings
    • 7.7.5 Applikon Biotechnology (Getinge) Recent Development
  • 7.8 Bioengineering AG
    • 7.8.1 Bioengineering AG Company Information
    • 7.8.2 Bioengineering AG Introduction and Business Overview
    • 7.8.3 Bioengineering AG Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Bioengineering AG Perfusion Bioreactors Product Offerings
    • 7.8.5 Bioengineering AG Recent Development
  • 7.9 3D Biotek
    • 7.9.1 3D Biotek Company Information
    • 7.9.2 3D Biotek Introduction and Business Overview
    • 7.9.3 3D Biotek Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 3D Biotek Perfusion Bioreactors Product Offerings
    • 7.9.5 3D Biotek Recent Development
  • 7.10 PBS Biotech, Inc.
    • 7.10.1 PBS Biotech, Inc. Company Information
    • 7.10.2 PBS Biotech, Inc. Introduction and Business Overview
    • 7.10.3 PBS Biotech, Inc. Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 PBS Biotech, Inc. Perfusion Bioreactors Product Offerings
    • 7.10.5 PBS Biotech, Inc. Recent Development
  • 7.11 Cell Culture Company
    • 7.11.1 Cell Culture Company Company Information
    • 7.11.2 Cell Culture Company Introduction and Business Overview
    • 7.11.3 Cell Culture Company Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Cell Culture Company Perfusion Bioreactors Product Offerings
    • 7.11.5 Cell Culture Company Recent Development
  • 7.12 Zellwerk GmbH
    • 7.12.1 Zellwerk GmbH Company Information
    • 7.12.2 Zellwerk GmbH Introduction and Business Overview
    • 7.12.3 Zellwerk GmbH Perfusion Bioreactors Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Zellwerk GmbH Perfusion Bioreactors Product Offerings
    • 7.12.5 Zellwerk GmbH Recent Development

8 Industry Chain Analysis

  • 8.1 Perfusion Bioreactors Industrial Chain
  • 8.2 Perfusion Bioreactors Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Perfusion Bioreactors Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Perfusion Bioreactors Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Perfusion Bioreactors Market Trends
  • Table 2. Perfusion Bioreactors Market Drivers & Opportunity
  • Table 3. Perfusion Bioreactors Market Challenges
  • Table 4. Perfusion Bioreactors Market Restraints
  • Table 5. Global Perfusion Bioreactors Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Perfusion Bioreactors Revenue Market Share by Company (2020-2025)
  • Table 7. Global Perfusion Bioreactors Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Perfusion Bioreactors Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Perfusion Bioreactors Price by Company (2020-2025) & (USD/Unit)
  • Table 10. Key Manufacturers Perfusion Bioreactors Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Perfusion Bioreactors Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Perfusion Bioreactors
  • Table 13. Global Perfusion Bioreactors Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Perfusion Bioreactors as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Perfusion Bioreactors Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Perfusion Bioreactors Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Perfusion Bioreactors Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Perfusion Bioreactors Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Perfusion Bioreactors Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Perfusion Bioreactors Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Perfusion Bioreactors Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Perfusion Bioreactors Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Perfusion Bioreactors Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Perfusion Bioreactors Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Perfusion Bioreactors Price by Type (2020-2025) & (USD/Unit)
  • Table 27. Global Perfusion Bioreactors Price by Type (2026-2031) & (USD/Unit)
  • Table 28. Global Perfusion Bioreactors Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Perfusion Bioreactors Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Perfusion Bioreactors Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Perfusion Bioreactors Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Perfusion Bioreactors Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Perfusion Bioreactors Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Perfusion Bioreactors Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Perfusion Bioreactors Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Perfusion Bioreactors Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Perfusion Bioreactors Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Perfusion Bioreactors Price by Application (2020-2025) & (USD/Unit)
  • Table 39. Global Perfusion Bioreactors Price by Application (2026-2031) & (USD/Unit)
  • Table 40. Global Perfusion Bioreactors Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Perfusion Bioreactors Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Perfusion Bioreactors Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Perfusion Bioreactors Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Perfusion Bioreactors Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Perfusion Bioreactors Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Perfusion Bioreactors Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Perfusion Bioreactors Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Perfusion Bioreactors Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Perfusion Bioreactors Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Perfusion Bioreactors Average Price by Region (2020-2025) & (USD/Unit)
  • Table 51. Global Perfusion Bioreactors Average Price by Region (2026-2031) & (USD/Unit)
  • Table 52. Key Countries/Regions Perfusion Bioreactors Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Perfusion Bioreactors Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Perfusion Bioreactors Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Perfusion Bioreactors Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Perfusion Bioreactors Sales Volume, (2026-2031) & (K Units)
  • Table 57. Sartorius AG Company Information
  • Table 58. Sartorius AG Introduction and Business Overview
  • Table 59. Sartorius AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 60. Sartorius AG Perfusion Bioreactors Product Offerings
  • Table 61. Sartorius AG Recent Development
  • Table 62. Cytiva Company Information
  • Table 63. Cytiva Introduction and Business Overview
  • Table 64. Cytiva Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 65. Cytiva Perfusion Bioreactors Product Offerings
  • Table 66. Cytiva Recent Development
  • Table 67. Thermo Fisher Company Information
  • Table 68. Thermo Fisher Introduction and Business Overview
  • Table 69. Thermo Fisher Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 70. Thermo Fisher Perfusion Bioreactors Product Offerings
  • Table 71. Thermo Fisher Recent Development
  • Table 72. Eppendorf AG Company Information
  • Table 73. Eppendorf AG Introduction and Business Overview
  • Table 74. Eppendorf AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 75. Eppendorf AG Perfusion Bioreactors Product Offerings
  • Table 76. Eppendorf AG Recent Development
  • Table 77. ZETA Company Information
  • Table 78. ZETA Introduction and Business Overview
  • Table 79. ZETA Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 80. ZETA Perfusion Bioreactors Product Offerings
  • Table 81. ZETA Recent Development
  • Table 82. Infors HT Company Information
  • Table 83. Infors HT Introduction and Business Overview
  • Table 84. Infors HT Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 85. Infors HT Perfusion Bioreactors Product Offerings
  • Table 86. Infors HT Recent Development
  • Table 87. Applikon Biotechnology (Getinge) Company Information
  • Table 88. Applikon Biotechnology (Getinge) Introduction and Business Overview
  • Table 89. Applikon Biotechnology (Getinge) Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 90. Applikon Biotechnology (Getinge) Perfusion Bioreactors Product Offerings
  • Table 91. Applikon Biotechnology (Getinge) Recent Development
  • Table 92. Bioengineering AG Company Information
  • Table 93. Bioengineering AG Introduction and Business Overview
  • Table 94. Bioengineering AG Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 95. Bioengineering AG Perfusion Bioreactors Product Offerings
  • Table 96. Bioengineering AG Recent Development
  • Table 97. 3D Biotek Company Information
  • Table 98. 3D Biotek Introduction and Business Overview
  • Table 99. 3D Biotek Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 100. 3D Biotek Perfusion Bioreactors Product Offerings
  • Table 101. 3D Biotek Recent Development
  • Table 102. PBS Biotech, Inc. Company Information
  • Table 103. PBS Biotech, Inc. Introduction and Business Overview
  • Table 104. PBS Biotech, Inc. Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 105. PBS Biotech, Inc. Perfusion Bioreactors Product Offerings
  • Table 106. PBS Biotech, Inc. Recent Development
  • Table 107. Cell Culture Company Company Information
  • Table 108. Cell Culture Company Introduction and Business Overview
  • Table 109. Cell Culture Company Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 110. Cell Culture Company Perfusion Bioreactors Product Offerings
  • Table 111. Cell Culture Company Recent Development
  • Table 112. Zellwerk GmbH Company Information
  • Table 113. Zellwerk GmbH Introduction and Business Overview
  • Table 114. Zellwerk GmbH Perfusion Bioreactors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
  • Table 115. Zellwerk GmbH Perfusion Bioreactors Product Offerings
  • Table 116. Zellwerk GmbH Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Perfusion Bioreactors Downstream Customers
  • Table 120. Perfusion Bioreactors Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Perfusion Bioreactors Product Picture
  • Figure 2. Global Perfusion Bioreactors Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Perfusion Bioreactors Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Perfusion Bioreactors Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Perfusion Bioreactors Sales Price (2020-2031) & (USD/Unit)
  • Figure 6. Perfusion Bioreactors Report Years Considered
  • Figure 7. Global Perfusion Bioreactors Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Perfusion Bioreactors Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Perfusion Bioreactors Revenue in 2024
  • Figure 10. Perfusion Bioreactors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Small Scale (<=100 Liters) Picture
  • Figure 12. Mid-Scale (100 to 1,000 Liters) Picture
  • Figure 13. Large Scale (>1,000 Liters) Picture
  • Figure 14. Global Perfusion Bioreactors Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Perfusion Bioreactors Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Perfusion Bioreactors Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Perfusion Bioreactors Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Perfusion Bioreactors Price by Type (2020-2031) & (USD/Unit)
  • Figure 19. Product Picture of Biopharmaceutical
  • Figure 20. Product Picture of Biotechnology
  • Figure 21. Product Picture of Others
  • Figure 22. Global Perfusion Bioreactors Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Perfusion Bioreactors Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Perfusion Bioreactors Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 25. Global Perfusion Bioreactors Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Perfusion Bioreactors Price by Application (2020-2031) & (USD/Unit)
  • Figure 27. North America Perfusion Bioreactors Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Perfusion Bioreactors Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Perfusion Bioreactors Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Perfusion Bioreactors Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Perfusion Bioreactors Sales Volume (%), (2020-2031)
  • Figure 39. United States Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Perfusion Bioreactors Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Perfusion Bioreactors Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Perfusion Bioreactors Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Perfusion Bioreactors Industrial Chain
  • Figure 61. Perfusion Bioreactors Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed